SCHEMBL4883781

SCHEMBL4883781

CC(C)(C)OC(=O)NCCOCCSc1cc2c3c(c1)c(=O)c(C(=O)O)cn3C(C)(C)OC2=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.35
CNR2 P34972 3/20 0.35
DDB1 Q16531 4/20 0.33
CRBN Q96SW2 4/20 0.33
MALT1 Q9UDY8 1/20 0.33
IDO1 P14902 1/20 0.33
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
NCOA1 Q15788 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
PDK2 Q15119 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4136252 0.78 KDM4E (0.33) BCHECNR2DDB1CRBNIDO1
SCHEMBL5313782 0.75 KDM4E (0.51) DDB1CRBNKDM4EALDH1A1LMNA
SCHEMBL4143470 0.75 KDM4E (0.51) DDB1CRBNKDM4EALDH1A1LMNA
SCHEMBL4143472 0.75 KDM4E (0.51) DDB1CRBNKDM4EALDH1A1LMNA
SCHEMBL3296288 0.73 BCHE (0.35) BCHECNR2DDB1CRBNMALT1
SCHEMBL4186321 0.67 SIGMAR1 (0.36) KDM4EMEN1KMT2A
SCHEMBL4186330 0.67 SIGMAR1 (0.36) KDM4EMEN1KMT2A
SCHEMBL3983514 0.66 ALDH1A1 (0.51) KDM4EMEN1ALDH1A1LMNAHPGD
SCHEMBL3983498 0.66 ALDH1A1 (0.51) KDM4EMEN1ALDH1A1LMNAHPGD
SCHEMBL3293003 0.66 IDO1 (0.36) MALT1IDO1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096829-A1 Macrolone Compounds GLAXO GROUP LIMITED (GB) 2008-04-24 US disclosed
EP-1824497-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2007-08-29 EP disclosed
WO-2006050943-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096829-A1 Macrolone Compounds MRPL21, MRPS18A, MRPL19 BCHE 3029/4885CNR2 4739/4885DDB1 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.